Press Release: Second Genome : Second Genome Presents Preclinical Data at Crohn's & Colitis Foundation's IBD Innovate Conference for Potential First in Class Mucosal Healing Therapeutic SG-5-00455

 BRISBANE, Calif., Nov. 18, 2021 /PRNewswire/ -- Second Genome, a biotechnology company that leverages its proprietary platform sg-4sight to discover and develop precision therapies and biomarkers, presented preclinical data from its mucosal...